BGM
Get informed when a big investor buys or sells
+ FollowUndervalued by 283.9% based on the discounted cash flow analysis.
| Market cap | $64.82 Million |
|---|---|
| Enterprise Value | $61.02 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.2 |
| Beta | 1.82 |
| Outstanding Shares | 31,615,463 |
| P/E Ratio | -1.62 |
|---|---|
| PEG | 0.45 |
| Price to Sales | 0.16 |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | 0.83 |
| Enterprise Value to EBIT | -7.25 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.03 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.66%▼ 0.08% |
|---|---|
| Total Invested | $63,385▼ 92.69% |
| Investors Holding | 14▲ 6.00% |
No data
Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycl...